Antibody-mediated rejection diagnosed in early protocol biopsies in high immunological risk kidney transplant recipients.

Carolt Arana AliagaEvelyn HermidaJordi RoviraJosé Luis CaroDavid CucchiariAna Belén LarqueEduard PalouJuan TorresEnrique Montagud-MarrahiElena Cuadrado-PáyanDiana Rodríguez-EspinosaJudit CachoAngela GonzalezJohanna ReinosoCarlos NicolauNuria EsforzadoVicente TorregrosaGastón PiñeiroIgnacio RevueltaFederico CofanFritz DiekmannPedro Ventura-AguiarFederico Oppenheimer

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2024)

Early protocol biopsies play a pivotal role in the early detection of veABMR in high-risk immunological patients. Patients with veABMR face significant risks of graft loss, despite early treatment of rejection.

Keyphrases

randomized controlled trial
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes
ultrasound guided
risk assessment
climate change
replacement therapy